SCHEMBL24796266

SCHEMBL24796266

O=C(O)CSCC(=O)N1CCNC1=O

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.48
FAAH O00519 1/20 0.47
NAAA Q02083 1/20 0.47
TDP1 Q9NUW8 1/20 0.45
ALDH1A1 P00352 3/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP2D6 P10635 1/20 0.41
HIF1A Q16665 1/20 0.41
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26746265 0.81 FAAH (0.47) GAAFAAHNAAATDP1ALDH1A1
SCHEMBL24795938 0.77 L3MBTL1 (0.45) GAAFAAHNAAATDP1ALDH1A1
SCHEMBL9802368 0.77 FAAH (0.60) GAAFAAHNAAATDP1ALDH1A1
SCHEMBL24796265 0.75 GAA (0.39) GAAFAAHNAAATDP1ALDH1A1
SCHEMBL10434746 0.74 FAAH (0.56) GAAFAAHNAAATDP1ALDH1A1
SCHEMBL24795935 0.73 KMT2A (0.38) GAAFAAHNAAATDP1ALDH1A1
SCHEMBL21389364 0.72 FAAH (0.42) GAAFAAHNAAATDP1ALDH1A1
SCHEMBL3392525 0.72 NAAA (0.74) GAAFAAHNAAATDP1ALDH1A1
SCHEMBL20633412 0.72 FAAH (0.54) GAAFAAHNAAATDP1ALDH1A1
SCHEMBL11372041 0.72 FAAH (0.64) GAAFAAHNAAATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS CARMOT THERAPEUTICS, INC. 2023-11-09 US disclosed
US-11535660-B1 Modulators of G-protein coupled receptors Cannot Therapeutics, Inc. (US) 2022-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357347-A1 MODULATORS OF G-PROTEIN COUPLED RECEPTORS GIPR, GLP1R, GCGR GAA 1526/4885FAAH 875/4885NAAA 2360/4885
US-11535660-B1 Modulators of G-protein coupled receptors GIPR, GLP1R, GCGR GAA 1536/4885FAAH 841/4885NAAA 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.